Else Nutrition Holdings Inc (TSX:BABY)

C$ 0.21 0.005 (2.44%) Market Cap: 30.33 Mil Enterprise Value: 30.34 Mil PE Ratio: 0 PB Ratio: 9.13 GF Score: 32/100

Q1 2024 Else Nutrition Holdings Inc Earnings Call Transcript
May 15, 2024

C$0.245 (-18.33%)

Earnings
Q4 2023 Else Nutrition Holdings Inc Earnings Call Transcript
Apr 01, 2024

C$0.285 (-3.39%)

Earnings
Q3 2023 Else Nutrition Holdings Inc Earnings Call Transcript
Nov 14, 2023

C$0.41 (-42.25%)

Earnings
Q2 2023 Else Nutrition Holdings Inc Earnings Call Transcript
Aug 14, 2023

C$0.54 (-18.18%)

Earnings
Else Nutrition Holdings Inc at Lytham Partners Spring Investor Conference- Advancements in Healthy Nutrition Pannel Transcript
May 18, 2023
Else Nutrition Holdings Inc at Lytham Partners Spring Investor Conference Transcript
May 18, 2023
Q1 2023 Else Nutrition Holdings Inc Earnings Call Transcript
May 15, 2023

C$0.78 (-1.27%)

Earnings
Q4 2022 Else Nutrition Holdings Inc Earnings Call Transcript
Mar 31, 2023

C$0.9 (+4.65%)

Earnings
Else Nutrition Holdings Inc at OTC Markets Life Sciences Investor Forum Transcript
Sep 15, 2022
Q2 2022 Else Nutrition Holdings Inc Earnings Call Transcript
Aug 15, 2022

C$0.92 (+6.98%)

Earnings
Else Nutrition Holdings Inc at OTC Markets Life Sciences Virtual Investor Forum Transcript
Jun 23, 2022
Q1 2022 Else Nutrition Holdings Inc Earnings Call Transcript
May 16, 2022

C$1.26 (+5.88%)

Earnings
Else Nutrition Holdings Inc at Lytham Partners Winter Investor Conference (Virtual) Transcript
Dec 13, 2021
Else Nutrition Holdings Inc Investor And Shareholders Conference Transcript
Nov 18, 2021

Q2 2022 Else Nutrition Holdings Inc Earnings Call Transcript

Aug 15, 2022 / 03:00PM GMT

Release Date Price: C$0.92 (+6.98%)

Transcript

Operator

Good day and welcome to the Else Nutrition second quarter 2022 update conference call. I would like to turn the call over to Ben Shamsian with Lytham Partners. Please go ahead.

Ben Shamsian

Lytham Partners - Analyst

Thank you for joining us today for Else Nutrition's second quarter 2022 conference call. With us on the call representing the company today is Hamutal Yitzhak, Else Nutrition's CEO. At the conclusion of today's prepared remarks, Hamutal will answers some questions that were sent to us by investors and other questions we think are relevant to investors as well.

Before we begin with prepared remarks, just a couple of comments. Today's call will contain forward-looking statements that are based on current assumptions and subject to risks and uncertainties that could cause actual results to differ materially from those projected. And the company undertakes no obligation to update these statements except as required by law.

Information about these risks and uncertainties are included in the company's filings, as well as periodic

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.